PharmaEssentia Corp Sustainability Profile
PharmaEssentia Corp., a leading biopharmaceutical company headquartered in Taiwan (TW), is dedicated to the development and commercialisation of innovative therapies for patients with rare diseases. Founded in 2003, the company has made significant strides in the industry, particularly in the fields of haematology and oncology. PharmaEssentia's flagship product, a novel treatment for essential thrombocythemia, exemplifies its commitment to addressing unmet medical needs with unique, scientifically-backed solutions. With a strong presence in Asia and expanding operations in global markets, PharmaEssentia has established itself as a key player in the biopharmaceutical landscape, recognised for its rigorous research and development efforts. The company continues to focus on delivering high-quality, effective therapies that improve patient outcomes and enhance quality of life.
DitchCarbon Score
How does PharmaEssentia Corp's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PharmaEssentia Corp's score of 37 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PharmaEssentia Corp's reported carbon emissions
PharmaEssentia Corp, headquartered in Taiwan (TW), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. In terms of climate commitments, PharmaEssentia has not outlined any reduction targets or initiatives, nor have they made any climate pledges. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for PharmaEssentia to establish clear emissions reduction goals and engage in climate initiatives to align with global standards and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 707,230 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 3,055,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 1,492,660 | 000,000 | 000,000 | 000,000 | 000,000 |
How Carbon Intensive is PharmaEssentia Corp's Industry?
How Carbon Intensive is PharmaEssentia Corp's Location?
PharmaEssentia Corp's Scope 3 Categories Breakdown
PharmaEssentia Corp's Scope 3 emissions, which decreased by 84% last year and decreased by approximately 93% since 2019, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 3% of total emissions under the GHG Protocol, with "Upstream Transportation & Distribution" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
PharmaEssentia Corp's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
PharmaEssentia Corp has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
